Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis

V Salvestrini, S Caini, M Scricciolo, M Saerens… - Frontiers in …, 2024 - frontiersin.org
Introduction: Over the past years, there has been a growing interest in the role of
immunotherapy in locally advanced (LA) and recurrent and metastatic head and neck …

Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised …

J Guigay, C Ortholan, D Vansteene… - The Lancet Healthy …, 2024 - thelancet.com
Background At present, there is no established standard treatment for frail older patients with
recurrent or metastatic head and neck squamous cell carcinoma. We aimed to compare the …

Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a …

J Guigay, H Le Caer, FR Ferrand… - The Lancet Healthy …, 2024 - thelancet.com
Background A standard treatment for fit, older patients with recurrent or metastatic head and
neck squamous cell carcinoma (HNSCC) is yet to be established. In the previous EXTREME …

[HTML][HTML] Onkologische Ergebnisse der Radiotherapie bei Patientinnen und Patienten mit lokal rezidivierten und fernmetastasierten Kopf-Hals-Tumoren-Unizentrische …

JK Schleifenbaum - 2024 - kups.ub.uni-koeln.de
Name: Julia Katharina Schleifenbaum Titel: Onkologische Ergebnisse der Radiotherapie bei
Patientinnen und Patienten mit lokal rezidivierten und fernmetastasierten Kopf-Hals …